by Mihai Ioan | Jul 8, 2026 | Pharma
Date: 03 Jul 2026 Munich, Germany – A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers...
by Mihai Ioan | Jun 23, 2026 | Pharma
Key takeaways The world’s leading cardiology experts will convene in Munich for ESC Congress 2026. The event takes place from 28 to 31 August, with the press programme beginning on 27 August. This year’s spotlight on artificial intelligence will explore the...
by Mihai Ioan | May 26, 2026 | Pharma
Key takeaways The study of 112,395 people includes a detailed analysis of diet and food ingredients. Researchers found eight preservative food additives linked to high blood pressure or cardiovascular disease. The highest risks were in people who ate the most...
by Mihai Ioan | May 26, 2026 | Pharma
Key takeaways: Cardiovascular disease is the leading cause of death in women. Women are more likely to have undiagnosed and untreated cardiovascular disease. Dedicated women’s heart centres are needed to improve diagnosis, treatment and care. Sophia...
by Mihai Ioan | May 13, 2026 | Pharma
The scientific programme of ESMO Breast Cancer 2026 highlighted the accelerating integration of precision oncology into breast cancer prevention, disease monitoring, and survivorship care. Across sessions dedicated to early detection, translational research, and early...
by Mihai Ioan | May 7, 2026 | Pharma
The ESMO Breast Cancer 2026 officially commenced on Wednesday, May 6, with a distinguished opening ceremony and award lecture that underscored the rapid pace of scientific advancement and the critical role of international collaboration in improving breast cancer...
